Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
2nd Annual Photo Contest - Enter Here!
Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board
Home > Ocular Surface Disease > Macular thickness not linked to eye strain, blurred vision, or photophobia
  • Ocular Surface Disease

Macular thickness not linked to eye strain, blurred vision, or photophobia

Ophthalmology 360

Factors such as tear break-up time, superficial punctate keratitis, and thickness of the ganglion cell complex play significant roles in the manifestation of common visual symptoms, including eye strain, blurred vision, and photophobia, according to a study.

Conducted with 6078 patients (3920 women, mean age 49.0 ± 20.4 years), the research focused on consecutive first-visit outpatients with best-corrected visual acuity better than 20/30 in both eyes, excluding those with a history of intra-ocular lens implantation and glaucoma.

The prevalence of each symptom was found to be 31.8% for eye strain, 22.5% for blurred vision, and 16.0% for photophobia. Notably, short tear break-up time (TBUT), superficial punctate keratitis (SPK), and thickness of ganglion cell complex (GCC) emerged as significant risk factors for eye strain, with respective odds ratios (OR) of 1.88, 1.44, and 1.30.

For blurred vision, short TBUT (OR 1.85), SPK (OR 1.24), and GCC (OR 0.59) played pivotal roles as risk factors. Conversely, Schirmer test value, peripapillary nerve fiber layer thickness, and full macular thickness did not demonstrate associations with the tested symptoms.

Finally, in terms of photophobia, short TBUT (OR 1.77) and SPK (OR 1.32) were identified as the main risk factors.

These findings not only highlight the prevalence of these common visual symptoms but also underline the importance of factors like tear break-up time and superficial punctate keratitis in their manifestation.

Reference
Ayaki M, Kuze M, Negishi K. Association of eye strain with dry eye and retinal thickness. PLoS One. 2023;18(10):e0293320. doi: 10.1371/journal.pone.0293320. PMID: 37862343; PMCID: PMC10588844.

Share

Related Content

  • Ocular Surface Disease

Symptomatic MGD shows distinct age-related clinical patterns

  • Ocular Surface Disease

Scleral lenses improve vision and symptoms across ocular surface diseases

  • Dry Eye

Spotlight on LACRIFILL®

  • Conference Roundup

CAM360 with a collagen shield provides rapid epithelial healing with better tolerability and safety than when used with bandage contact lenses

  • Conference Roundup

If your patient has recurrent chalazia, consider co-occurring Demodex blepharitis

  • Neurotrophic Keratitis

Novel anterior keratoplasty approach supports healing in refractory ocular surface disease

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Ophthalmology 360

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon